Drug Detail

Information about BEZ235 + MEK162

Generic Name
IND
BEZ235 + MEK162
Brand Name (US)
Manufacturer
Novartis
Drug Type
Kinase inhibitor
Delivery
Oral
Approval Status
Phase 1
Indications
Overall Strategy
Oncogenic Signal Path Based
Strategy
Block KIT Signal Path
Drug Category
PI3K/mTOR inhibitor + MEK inhibitor